Artemisinin Derivatives Stimulate DR5-Specific TRAIL-Induced Apoptosis by Regulating Wildtype P53

Artemisinin Derivatives Stimulate DR5-Specific TRAIL-Induced Apoptosis by Regulating Wildtype P53

Artemisinin derivatives, widely known as commercial anti-malaria drugs, may also have huge potential in treating cancer cells. It has been reported that artemisinin derivatives can overcome resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in liver and c...

Full description

Bibliographic Details
Main Authors: Xinyu Zhou, Sietske N. Zijlstra, Abel Soto-Gamez, Rita Setroikromo, Wim J. Quax
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Cancers
Subjects:
artemisinin
TRAIL
death receptors
colon cancer
3D spheroid
Online Access:https://www.mdpi.com/2072-6694/12/9/2514

Internet

https://www.mdpi.com/2072-6694/12/9/2514

Similar Items